Alpha Diagnostic International, Inc. Anti-Rat Cannabinoid receptor (CB2) IgG # 2, aff pure CB22-A

Anti-Rat Cannabinoid receptor (CB2) IgG # 2, aff pure General Information CB2 (rat 410 aa, mouse 347aa, human 360 aa; ~45% homology with CB1) also inhibit adenylate cyclase activity via a pertussis toxin-sensitive G-protein. Unlike CB1, CB2 does not modulate the activity of either Q-type Ca2+ or inwardly rectifying K+ channels SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Rat SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Affinity purified IgG SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen An 18 aa peptide (designated CB22-P control peptide) Cytoplasmic Epitope location ~C-terminus of rat CB2 (1) SpCrossreactivity The rat CB22-P peptide sequence is 83% conserved in mouse, and 82% in human CB2. No significant sequence homology exists with CB1. Antibody crossreactivity in various species is not established For research use only, not for diagnostic or therapeutic use.